Kerry Bernal, MD
Anatomic Pathology & Clinical Pathology · Omaha, NENPI 1457318883
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Johnson & Johnson at 34.9% of the total.
Across 15 payments — averaging $14.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$74
- Intercept Pharmaceuticals, Inc.$32
- Takeda Pharmaceuticals U.S.A., Inc.$29
- Amgen$18
- Ardelyx, Inc.$17
- Celltrion USA Inc.$16
- plus $27 from 2 others
What the payments were for
- Food & beverage$20194%
- Other$136%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 6 | $74 |
| Intercept Pharmaceuticals, Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Amgen | 1 | $18 |
| Ardelyx, Inc. | 1 | $17 |
| Celltrion USA Inc. | 1 | $16 |
| Bristol Myers Squibb | 1 | $14 |
| Baxter Healthcare | 1 | $13 |
How this compares
$213 in reported general payments places this provider in the 70th percentile of 83 anatomic pathology & clinical pathology providers in Nebraska.
See all anatomic pathology & clinical pathology providers in Nebraska →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Omaha
- Scott KoepsellOmaha$117K
- Samuel CohenOmaha$16K
- Chunyan LiuOmaha$16K
- Jill HagenkordOmaha$12K
- Sadiq ZamanOmaha$5K
- Poonam SharmaOmaha$4K
- Carmelita AlvaresOmaha$1K
- Justin MiskoOmaha$1K
- Teresa KarreOmaha$956
- Timothy GreinerOmaha$906
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.